Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-016-2795-7
Published Online: 2016-08-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reiss, Samantha N. http://orcid.org/0000-0002-4926-9508
Buie, Larry W.
Adel, Nelly
Goldman, Debra A.
Devlin, Sean M.
Douer, Dan
License valid from 2016-08-20